Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
Go back to Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results| (NASDAQ: FULC) | Delayed: 3.79 +0.01 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.78 | 52 Week High | $ | |||
| Open | $3.80 | 52 Week Low | $ | |||
| Day High | $3.81 | P/E | N/A | |||
| Day Low | $3.77 | EPS | $ | |||
| Volume | 145,956 | |||||

